Plasma circulating cell-free mitochondrial DNA in depressive disorders.

<h4>Background</h4>Plasma circulating cell-free mitochondrial DNA (ccf-mtDNA) is an immunogenic molecule and a novel biomarker of psychiatric disorders. Some previous studies reported increased levels of ccf-mtDNA in unmedicated depression and recent suicide attempters, while other studi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Johan Fernström, Lars Ohlsson, Marie Asp, Eva Lavant, Amanda Holck, Cécile Grudet, Åsa Westrin, Daniel Lindqvist
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/32b817a674a84feaa37f3d641f42546a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:32b817a674a84feaa37f3d641f42546a
record_format dspace
spelling oai:doaj.org-article:32b817a674a84feaa37f3d641f42546a2021-12-02T20:04:18ZPlasma circulating cell-free mitochondrial DNA in depressive disorders.1932-620310.1371/journal.pone.0259591https://doaj.org/article/32b817a674a84feaa37f3d641f42546a2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0259591https://doaj.org/toc/1932-6203<h4>Background</h4>Plasma circulating cell-free mitochondrial DNA (ccf-mtDNA) is an immunogenic molecule and a novel biomarker of psychiatric disorders. Some previous studies reported increased levels of ccf-mtDNA in unmedicated depression and recent suicide attempters, while other studies found unchanged or decreased ccf-mtDNA levels in depression. Inconsistent findings across studies may be explained by small sample sizes and between-study variations in somatic and psychiatric co-morbidity or medication status.<h4>Methods</h4>We measured plasma ccf-mtDNA in a cohort of 281 patients with depressive disorders and 49 healthy controls. Ninety-three percent of all patients were treated with one or several psychotropic medications. Thirty-six percent had a personality disorder, 13% bipolar disorder. All analyses involving ccf-mtDNA were a priori adjusted for age and sex.<h4>Results</h4>Mean levels in ccf-mtDNA were significantly different between patients with a current depressive episode (n = 236), remitted depressive episode (n = 45) and healthy controls (n = 49) (f = 8.3, p<0.001). Post-hoc tests revealed that both patients with current (p<0.001) and remitted (p = 0.002) depression had lower ccf-mtDNA compared to controls. Within the depressed group there was a positive correlation between ccf-mtDNA and "inflammatory depression symptoms" (r = 0.15, p = 0.02). We also found that treatment with mood stabilizers lamotrigine, valproic acid or lithium was associated with lower ccf-mtDNA (f = 8.1, p = 0.005).<h4>Discussion</h4>Decreased plasma ccf-mtDNA in difficult-to-treat depression may be partly explained by concurrent psychotropic medications and co-morbidity. Our findings suggest that ccf-mtDNA may be differentially regulated in different subtypes of depression, and this hypothesis should be pursued in future studies.Johan FernströmLars OhlssonMarie AspEva LavantAmanda HolckCécile GrudetÅsa WestrinDaniel LindqvistPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 11, p e0259591 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Johan Fernström
Lars Ohlsson
Marie Asp
Eva Lavant
Amanda Holck
Cécile Grudet
Åsa Westrin
Daniel Lindqvist
Plasma circulating cell-free mitochondrial DNA in depressive disorders.
description <h4>Background</h4>Plasma circulating cell-free mitochondrial DNA (ccf-mtDNA) is an immunogenic molecule and a novel biomarker of psychiatric disorders. Some previous studies reported increased levels of ccf-mtDNA in unmedicated depression and recent suicide attempters, while other studies found unchanged or decreased ccf-mtDNA levels in depression. Inconsistent findings across studies may be explained by small sample sizes and between-study variations in somatic and psychiatric co-morbidity or medication status.<h4>Methods</h4>We measured plasma ccf-mtDNA in a cohort of 281 patients with depressive disorders and 49 healthy controls. Ninety-three percent of all patients were treated with one or several psychotropic medications. Thirty-six percent had a personality disorder, 13% bipolar disorder. All analyses involving ccf-mtDNA were a priori adjusted for age and sex.<h4>Results</h4>Mean levels in ccf-mtDNA were significantly different between patients with a current depressive episode (n = 236), remitted depressive episode (n = 45) and healthy controls (n = 49) (f = 8.3, p<0.001). Post-hoc tests revealed that both patients with current (p<0.001) and remitted (p = 0.002) depression had lower ccf-mtDNA compared to controls. Within the depressed group there was a positive correlation between ccf-mtDNA and "inflammatory depression symptoms" (r = 0.15, p = 0.02). We also found that treatment with mood stabilizers lamotrigine, valproic acid or lithium was associated with lower ccf-mtDNA (f = 8.1, p = 0.005).<h4>Discussion</h4>Decreased plasma ccf-mtDNA in difficult-to-treat depression may be partly explained by concurrent psychotropic medications and co-morbidity. Our findings suggest that ccf-mtDNA may be differentially regulated in different subtypes of depression, and this hypothesis should be pursued in future studies.
format article
author Johan Fernström
Lars Ohlsson
Marie Asp
Eva Lavant
Amanda Holck
Cécile Grudet
Åsa Westrin
Daniel Lindqvist
author_facet Johan Fernström
Lars Ohlsson
Marie Asp
Eva Lavant
Amanda Holck
Cécile Grudet
Åsa Westrin
Daniel Lindqvist
author_sort Johan Fernström
title Plasma circulating cell-free mitochondrial DNA in depressive disorders.
title_short Plasma circulating cell-free mitochondrial DNA in depressive disorders.
title_full Plasma circulating cell-free mitochondrial DNA in depressive disorders.
title_fullStr Plasma circulating cell-free mitochondrial DNA in depressive disorders.
title_full_unstemmed Plasma circulating cell-free mitochondrial DNA in depressive disorders.
title_sort plasma circulating cell-free mitochondrial dna in depressive disorders.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/32b817a674a84feaa37f3d641f42546a
work_keys_str_mv AT johanfernstrom plasmacirculatingcellfreemitochondrialdnaindepressivedisorders
AT larsohlsson plasmacirculatingcellfreemitochondrialdnaindepressivedisorders
AT marieasp plasmacirculatingcellfreemitochondrialdnaindepressivedisorders
AT evalavant plasmacirculatingcellfreemitochondrialdnaindepressivedisorders
AT amandaholck plasmacirculatingcellfreemitochondrialdnaindepressivedisorders
AT cecilegrudet plasmacirculatingcellfreemitochondrialdnaindepressivedisorders
AT asawestrin plasmacirculatingcellfreemitochondrialdnaindepressivedisorders
AT daniellindqvist plasmacirculatingcellfreemitochondrialdnaindepressivedisorders
_version_ 1718375593231253504